Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
FWIW. I think something is being worked on now and this can't be finalised until we have clarity with 737. There is no technical or clinical reason why a CTA should take this long complete. I think it is being held back along with the trading statement that is due. I think we are reaching a pivot point that we will cross in the next few weeks. Licence\TO or Do P1 ourselves. Some cash or even a direction of travel for 737 would help us walk away from a bad deal.
Got it, Potnak
For myself, I’m already looking to next year for 1801. I think the real action will drop when 1801 exits the P1 trial then.
Bill
Billy, When posters here say we're developing a Covid pill. We're not. We do have do have some good data if someone else wants too though. Got to get through P1 before we are developing anything. It could be 2023 before we even know indication what we trial 1801 in. P1 end of this year, if successful, P1a in a named indication early next year. A buyout or chunky licence deal will put us all out of our misery.
Putnak, what do you mean when you say ‘covid pill myth’?
Thanks,
Bill
The deal was between CRT and Pronai. The board have stated on numerous occasions that they have no influence and that they get news when we do. Tim and board will be waiting for a red dot just as we are. Its my bigest bug bear on here (this and the covid pill myth). We aren't owed any expalantion from Sierra or GSK. If anything, the Sareum Twiiter activist should be targeting the CRT, it's their deal and they wil know whats happening. For the record, I think GSK taking it is a good move for Sareum but Billy Bunter is correct, SRA737 will just become part of the GSK pipeline and we'll be scanning the trading updates for news. More of the same but with a much bigger budget to progress.
Tend to agree Potnak but it has always beggared belief that Sareum should part finance the CRT project and not have a seat at the table but having said that surely Sareum are entitled to SOME sort of feedback? If not it must have been a contract laden with onerous clauses.
I can not believe that they would throw the baby out with the bathwater and say to Sierra "here you are chaps-do what you like and not a prob. if you don't want to give us any progress reports" do you??
GLA
I feel that once the dust settles on the Sierra deal we will get an offer for our 737 share ... Anything else may take a bit more time and bartering
I'm still of the opinion that SRA737 is part of a bigger picture that is being worked on. In terms of 737, Sareum are just a bystander. It isn't our compound anymore, we are not the major stakeholder and GSK doesn't owe Sareum shareholders any explanation. However, there is some intrinsic value in SRA737 for Sareum, even at this stage. Maybe £200 million? This value will feature in any TO negotiations and is possibly dependent on it. It's good that 737 has a new home or even a foster home but confirmation of the next steps could add some significant value here. I reckon August is going to be awash with news.
Metalbasher I think your post is the most relevant of all those that I have read today, it cuts through everything and hits the nail on the head perfectly as up until now the opportunity to expose SRA737 has been small time, GSK if it happens is the vehicle to make this happen. Fully concure with your post "Not Bothered about RNS timing,just pleased that a molecule which we have a share of is in the hands a top tier pharmaceutical company." That's it, simples, if there was ever a horse you would back to make this happen its GSK ... up until now we have not had such a real opportunity ...Awesome prospect ahead GLA.
Not Bothered about RNS timing,just pleased that a molecule which we have a share of is in the hands a top tier pharmaceutical company. GLA
We know they like an 11:00 RNS on a Thursday, last day of the month today too...
Whatever happens we know there are many exciting things happening behind the curtains, from all the good research posted here it is definately going to be roller coaster few weeks with what we know, have found and have shared.
(:-(
A minute to go until we find out perhaps? Gla x
We might just be at that point we've all been waiting for.
I wouldn't want to be......
Gla